d-amphetamine
Sponsors
National Institute on Drug Abuse (NIDA), The University of Texas Health Science Center, Houston, University of Illinois at Chicago, Biotie Therapies Inc., University of Pittsburgh
Conditions
Abuse PotentialAlcohol DependenceAnhedoniaCocaine AbuseCocaine DependenceCocaine Use DisorderCocaine-Related DisordersOpiate Dependence
Early Phase 1
Cocaine Use Disorder and Cortical Dopamine
CompletedNCT03349606
Start: 2010-06-02End: 2020-06-01Target: 30Updated: 2020-06-04
Brain Mechanisms in Young Adults
CompletedNCT03606473
Start: 2018-01-24End: 2020-08-31Updated: 2020-09-03
[C-11]NPA PET-amphetamine in Cocaine Use Disorders
RecruitingNCT05011760
Start: 2021-01-31End: 2028-09-01Target: 30Updated: 2025-06-05
Phase 1
Phase 2
Dextroamphetamine-Cocaine Behavioral Intervention - 5
CompletedNCT00000308
Start: 1995-09-30End: 2000-09-30Updated: 2017-01-12
Dextroamphetamine as an Adjunct in Cocaine Treatment - 1
CompletedNCT00000304
Start: 1997-08-31End: 2001-08-31Updated: 2017-01-12
Targeting Anhedonia in Cocaine Use Disorder
CompletedNCT02773212
Start: 2017-02-01End: 2022-04-04Updated: 2024-08-09
Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia
CompletedNCT04414930
Start: 2020-11-09End: 2024-12-30Updated: 2025-12-17
MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder
RecruitingNCT05790239
Start: 2025-03-01End: 2026-03-31Target: 40Updated: 2025-03-28